Working with a contract drug manufacturing and testing firm in the United Kingdom, 25 to 30 healthy volunteers are now ...

Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...

Chime Biologics, a leading global CDMO that enables its partners' success in biologics, today announced its continued ...

Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...

Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in ...

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

The field of central nervous system (CNS) drug development is awash with activity. And major new centres of research are ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Septerna discontinues phase 1 clinical trial of SEP-786; plans to advance next-generation oral small molecule PTH1R agonist: South San Francisco, California Friday, February 21, 2 ...

The FDA has granted orphan drug designation to the oral agent OPN-6602 for the treatment of patients with relapsed or ...